ClassID:

95376

C07D473/10 - CPC Classification

Classification description:

Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine

Recent Application in this class:
#1
20260062414
2026-03-05

NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF

#2
20200385683
2020-12-10

Composition and method for culturing organoids

#3
20200157063
2020-05-21

Method for preparation of alkylated or fluoro, chloro and fluorochloro alkylated compounds by heterogeneous cobalt catalysis

#4
20180148451
2018-05-31

Hydroxyl purine compounds and use thereof

#5
20180140607
2018-05-24

Hydroxyl purine compounds and use thereof

#6
20180127631
2018-05-10

Anti-ice nucleation activator

#7
20170320878
2017-11-09

Method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous catalysis

#8
20150376665
2015-12-31

PROCESS FOR PREPARING AN ENANTIOMERICALLY ENRICHED, DEUTERATED SECONDARY ALCOHOL FROM A CORRESPONDING KETONE WITHOUT REDUCING DEUTERIUM INCORPORATION

#9
20150322068
2015-11-12

Substituted xanthine derivatives

#10
20150119407
2015-04-30

Substituted xanthine derivatives

#11
20140296263
2014-10-02

SUBSTITUTED XANTHINE DERIVATIVES

#12
20140194447
2014-07-10

Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies

#13
20140046060
2014-02-13

METHOD OF UTILIZING RECYCLED DEUTERIUM OXIDE IN THE SYNTHESIS OF DEUTERATED COMPOUNDS

#14
20130324564
2013-12-05

POLYMORPHS OF (S)-1-(4,4,6,6,6-PENTADEUTERO-5-HYDROXYHEXYL)-3-7-DIMETHYL-1H-PURINE-2,6(3H,7H)-DIONE

#15
20130280768
2013-10-24

Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation

#16
20120252783
2012-10-04

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#17
20120252782
2012-10-04

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#18
20120040982
2012-02-16

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#19
20120035158
2012-02-09

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#20
20110144095
2011-06-16

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#21
20110144083
2011-06-16

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#22
20110003834
2011-01-06

PRODUCTION METHOD AND PRODUCTION APPARATUS FOR A HIGH THEOBROMINE-CONTAINING COMPOSITION

#23
20100204250
2010-08-12

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#24
20100173916
2010-07-08

Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions

#25
20100034954
2010-02-11

NUTRITIONALLY SUITABLE COCOA FOR ANIMAL FEED

#26
20090239886
2009-09-24

Substituted xanthine derivatives

#27
20090124796
2009-05-14

Nucleobase having perfluoroalkyl group and process for producing the same

#28
20070265284
2007-11-15

Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV

#29
20060247226
2006-11-02

XANTHINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

#30
20060211713
2006-09-21

Compounds having selective hydrolytic potentials

#31
20060205711
2006-09-14

Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions

#32
20050049262
2005-03-03

Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same